HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antitumor and anti-angiogenesis immunity induced by CR-SEREX-identified Xenopus RHAMM.

Abstract
Immunization with xenogeneic antigens is an attractive approach to induce cross-reactive humoral and cellular immunity to inhibit tumor growth or angiogenesis. To identify novel xenogenic targets for immunotherapy, we have developed a modified serological expression cloning (SEREX) strategy, termed Cross-reactive SEREX (CR-SEREX). Among 78 positive clones identified by CR-SEREX, Xenopus receptor for hyaluronic-acid-mediated motility (xRHAMM) was most frequently identified (18 times), indicating the strongest immunogenic potential for xenogenic immunotherapy. A DNA vaccine based on xRHAMM effectively induced a protective antitumor immunity against local tumor and lung metastasis in B16 melanoma mouse models. Angiogenesis was inhibited and cell apoptosis was increased within tumors. Antitumor activity of xRHAMM worked through stimulation of an antigen-specific cellular response as well as through a specific humoral response against RHAMM, as confirmed by the depletion of immune cell subsets in vivo. Thus, a xenogenic vaccine based on xRHAMM induced an effective immunity against B16 melanoma cells and endothelial cells.
AuthorsHan Shuo Yang, Dong Mei Zhang, Hong Xin Deng, Feng Peng, Yu Quan Wei
JournalCancer science (Cancer Sci) Vol. 101 Issue 4 Pg. 862-8 (Apr 2010) ISSN: 1349-7006 [Electronic] England
PMID20704574 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, Heterophile
  • Cancer Vaccines
  • Hyaluronan Receptors
  • Vaccines, DNA
Topics
  • Animals
  • Antigens, Heterophile (immunology)
  • Cancer Vaccines (immunology, therapeutic use)
  • Cloning, Molecular
  • Cross Reactions (immunology)
  • Hyaluronan Receptors (immunology)
  • Immunity, Cellular (immunology)
  • Melanoma, Experimental (blood supply, immunology, therapy)
  • Mice
  • Neovascularization, Pathologic (immunology)
  • Vaccines, DNA (genetics, immunology, therapeutic use)
  • Xenopus laevis (genetics, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: